Compile Data Set for Download or QSAR
maximum 50k data
Found 13 Enz. Inhib. hit(s) with all data for entry = 2586
TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Ralexar Therapeutics

US Patent
LigandPNGBDBM372421(US10246419, Compound 4)
Affinity DataEC50: <1.00E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Ralexar Therapeutics

US Patent
LigandPNGBDBM372422(US10246419, Compound 5)
Affinity DataEC50: <1.00E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Ralexar Therapeutics

US Patent
LigandPNGBDBM372423(US10246419, Compound 6)
Affinity DataEC50: <1.00E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Ralexar Therapeutics

US Patent
LigandPNGBDBM372424(US10246419, Compound 10 | US10246419, Compound 7)
Affinity DataEC50: <1.00E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Ralexar Therapeutics

US Patent
LigandPNGBDBM372425(US10246419, Compound 8)
Affinity DataEC50:  5.50E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Ralexar Therapeutics

US Patent
LigandPNGBDBM372426(US10246419, Compound 9)
Affinity DataEC50:  5.50E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Ralexar Therapeutics

US Patent
LigandPNGBDBM372433(US10246419, Compound 21)
Affinity DataEC50: <1.00E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Ralexar Therapeutics

US Patent
LigandPNGBDBM372428(US10246419, Compound 11)
Affinity DataEC50:  5.50E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Ralexar Therapeutics

US Patent
LigandPNGBDBM372429(US10246419, Compound 12)
Affinity DataEC50:  5.50E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Ralexar Therapeutics

US Patent
LigandPNGBDBM372430(1-(cyclopropylmethyl)- 5-(3'-(methylsulfonyl)- [1,...)
Affinity DataEC50: <1.00E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Ralexar Therapeutics

US Patent
LigandPNGBDBM372431(1-(sec-butyl)-5-(3'- (methylsulfonyl)-[1,1'- biphe...)
Affinity DataEC50: >1.00E+4nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Ralexar Therapeutics

US Patent
LigandPNGBDBM372432(1-cyclohexyl-5-(3'- (methylsulfonyl)-[1,1'- biphen...)
Affinity DataEC50: >1.00E+4nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Ralexar Therapeutics

US Patent
LigandPNGBDBM372424(US10246419, Compound 10 | US10246419, Compound 7)
Affinity DataEC50:  5.50E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent